These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
260 related items for PubMed ID: 20053983
1. Antifibrotic effect of Pirfenidone on orbital fibroblasts of patients with thyroid-associated ophthalmopathy by decreasing TIMP-1 and collagen levels. Kim H, Choi YH, Park SJ, Lee SY, Kim SJ, Jou I, Kook KH. Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3061-6. PubMed ID: 20053983 [Abstract] [Full Text] [Related]
2. Pirfenidone attenuates the IL-1β-induced hyaluronic acid increase in orbital fibroblasts from patients with thyroid-associated ophthalmopathy. Chung SA, Jeon BK, Choi YH, Back KO, Lee JB, Kook KH. Invest Ophthalmol Vis Sci; 2014 Apr 09; 55(4):2276-83. PubMed ID: 24627146 [Abstract] [Full Text] [Related]
3. Effects of pirfenidone on proliferation, migration, and collagen contraction of human Tenon's fibroblasts in vitro. Lin X, Yu M, Wu K, Yuan H, Zhong H. Invest Ophthalmol Vis Sci; 2009 Aug 09; 50(8):3763-70. PubMed ID: 19264889 [Abstract] [Full Text] [Related]
4. Pirfenidone attenuates IL-1β-induced COX-2 and PGE2 production in orbital fibroblasts through suppression of NF-κB activity. Choi YH, Back KO, Kim HJ, Lee SY, Kook KH. Exp Eye Res; 2013 Aug 09; 113():1-8. PubMed ID: 23664858 [Abstract] [Full Text] [Related]
5. Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis. Oku H, Shimizu T, Kawabata T, Nagira M, Hikita I, Ueyama A, Matsushima S, Torii M, Arimura A. Eur J Pharmacol; 2008 Aug 20; 590(1-3):400-8. PubMed ID: 18598692 [Abstract] [Full Text] [Related]
6. [Antifibrotic effect of pirfenidone on orbital fibroblasts in patients with thyroid-associated ophthalmopathy and its mechanisms]. Li DD, Liu Y, Yuan RR, Yu T, Yang B, Pang WY. Zhonghua Nei Ke Za Zhi; 2019 Mar 01; 58(3):185-190. PubMed ID: 30803176 [Abstract] [Full Text] [Related]
7. Antifibrotic effects of quercetin in primary orbital fibroblasts and orbital fat tissue cultures of Graves' orbitopathy. Yoon JS, Chae MK, Jang SY, Lee SY, Lee EJ. Invest Ophthalmol Vis Sci; 2012 Aug 31; 53(9):5921-9. PubMed ID: 22871832 [Abstract] [Full Text] [Related]
12. Pirfenidone inhibits the expression of HSP47 in TGF-beta1-stimulated human lung fibroblasts. Nakayama S, Mukae H, Sakamoto N, Kakugawa T, Yoshioka S, Soda H, Oku H, Urata Y, Kondo T, Kubota H, Nagata K, Kohno S. Life Sci; 2008 Jan 16; 82(3-4):210-7. PubMed ID: 18093617 [Abstract] [Full Text] [Related]
14. [Effect of dexamethasone on expression of intercellular adhesion molecule-1 in orbital fibroblasts from thyroid associated ophthalmopathy]. He WM, Luo QL, Zeng JH. Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan 16; 38(1):113-5. PubMed ID: 17294742 [Abstract] [Full Text] [Related]
17. Inhibition by triptolide of chemokine, proinflammatory cytokine, and adhesion molecule expression induced by lipopolysaccharide in corneal fibroblasts. Lu Y, Liu Y, Fukuda K, Nakamura Y, Kumagai N, Nishida T. Invest Ophthalmol Vis Sci; 2006 Sep 16; 47(9):3796-800. PubMed ID: 16936090 [Abstract] [Full Text] [Related]
18. Hyaluronic acid induces COX-2 expression via CD44 in orbital fibroblasts from patients with thyroid-associated ophthalmopathy. Lim HS, Back KO, Kim HJ, Choi YH, Park YM, Kook KH. Invest Ophthalmol Vis Sci; 2014 Oct 23; 55(11):7441-50. PubMed ID: 25342622 [Abstract] [Full Text] [Related]